Laxmi Organic Industries Ltd. · NSE:LXCHEM
Laxmi Organic Industries — Q2 FY2022 Earnings Presentation
27 slides from Laxmi Organic Industries's earnings presentation, Nov 3, 2021
Slide 1: Intimation to exchanges of investor presentation
November 3, 2021 BSE Limited National Stock Exchange Limited Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, 1st Floor, New Trading Ring, Bandra (E), Rotunda Building, P. J. Towers, Mumbai – 400 051 Dalal Street, Fort, Trading Symbol: LXCHEM Mumbai – 400 001 Scrip Code: 5432
Slide 2: Laxmi Organic Industries Reports Q2FY22 Results
LAXMI ORGANIC INDUSTRIES REPORTS Q2FY22 RESULTS Standalone Operating Revenue of ₹ 5,263 Mn Profit After Tax at ₹ 103 Mn Mumbai, November 3, 2021: Laxmi Organic Industries Limited (NSE: LXCHEM|BSE:543277|ISIN: INE576O0102), one of India’s leading specialty chemical manufacturers, has announced its fi
Slide 3: About Laxmi Organic Industries Ltd. (LXCHEM)
About Laxmi Organic Industries Ltd. (LXCHEM): Laxmi Organic Industries Ltd (LXCHEM) is a leading manufacturer of Acetyl Intermediates and Specialty Intermediates with almost three decades of experience in large scale manufacturing of chemicals. It is currently among the largest manufacturers of ethy
Slide 4: Investor Presentation – 3rd November, 2021
LAXMI ORGANIC INDUSTRIES LTD w w w. l a x m i . c o m Investor Presentation – 3rd November, 2021
Slide 5: Disclaimer
Disclaimer Certain statements and opinions with respect to the anticipated future performance of Laxmi Organics Ltd (Laxmi) in the presentation (“forward - looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to be
Slide 6: Agenda
Agenda 01 Company overview 02 Business 03 Strategy 04 Financials
Slide 7: Company overview
Company overview LAXMI ORGANIC INDUSTRIES LTD
Slide 8: Company overview
Company overview Large scale organic chemical Combined with YCPL the Only manufacturer of Diketene Forayed into high margin manufacturing for more than Company will become the derivatives in India with ~55% specialty fluorochemicals by three decades largest manufacturer of Ethyl market share acquisi
Slide 9: De-risked business model with diversified customer base
De-risked business model with diversified customer base India market - Growth Diversified customer base (2019-24 CAGR) % of revenue from sale of manufactured products & services Pharma Ingredients Pharma Ingredients (API) 11% 7% 11% 33% Agrochemicals & Fertilizers 10% 11% FY21 Dyes & Pigments 11% 11
Slide 10: De-risking through presence in different geographies
De-risking through presence in different geographies Robust export earnings Low dependence on a single export market (INR Mn) FY21 sale break-up 3,972 Europe 3,541 41% 3,293 Middle East 2,748 7% Russia Africa 17% China 1% 7% 19% Rest of Asia 8% Americas FY19 FY20 FY21 H1FY22 Arrangements for Custome
Slide 11: In-house Research & Development capabilities
In-house Research & Development capabilities Consistent technology absorption to develop R&D – Key growth driver of business new potential marketable products ¢ Developed five different chemistry platforms on ¢ Two DSIR recognised R&D facilities working on ketene, commercial scale diketene & other c
Slide 12: Business
Business LAXMI ORGANIC INDUSTRIES LTD
Slide 13: Overview of Acetyl Intermediates (AI) business
Overview of Acetyl Intermediates (AI) business Comprising of ETAC, acetaldehyde, ethanol & other customised solvents Revenue … Growing capacity utilisation Expanding manufacturing capabilities (INR Mn) 84% 84% 161,000 Acquisition of YCPL 9,139 MTPA 8,954 11,000 29,000 8,145 MTPA MTPA 80% Acetaldehyd
Slide 14: Overview of Specialty Intermediates (SI) business
Overview of Specialty Intermediates (SI) business Basket of 34+ products – ketene, diketene derivatives (esters, acetic anhydride, amides, arylides & others) Healthy revenue contribution from new products Highly versatile products (INR Mn) 51% 46% 48% Pharmaceutical 1 4,562 4,368 5,069 2 Agrochemica
Slide 15: Fluorospecialty – Differentiated position in chemical manufacturing
Fluorospecialty– Differentiated position in chemical manufacturing Growth drivers of fluorochemicals Diversification into high margin fluorospeciality chemicals… ¢ One in every 3 new APIs will be based on fluorine chemistry Miteni (Italy) Manufacturer of organic fluorospecialities & ¢ Upto 20% of ph
Slide 16: Strategy
Strategy LAXMI ORGANIC INDUSTRIES LTD
Slide 17: Strategy
Strategy Increasing global Continuing focus on Establishing the footprint innovation fluorospecialty business ¢ Creation of subsidiary in USA with an ¢ Leverage know-how in complex ¢ Capture market share of Miteni, aim of having a stock point in the US chemistries to add downstream & utilising exist
Slide 18: Financial performance
Financial performance LAXMI ORGANIC INDUSTRIES LTD
Slide 19: Management Commentary
Management Commentary Mr. Ravi Goenka Chairman & Managing Director “Our results for the half year remains encouraging and has nearly surpassed last whole year’s profitability. This has been due to our growing specialty business and a run-up of the Acetyls spreads in the first quarter. In the second
Slide 20: Half Yearly Profit and Loss Statement
Half Yearly Profit and Loss Statement Standalone Consolidated H1’22 Revenue Split (in INR Mn) (Standalone) PARTICULARS PARTICULARS H1FY22 H1FY21 H1FY22 H1FY21 (in INR Millions) (in INR Millions) Revenue From Revenue From Operations 12,160 7,451 Operations 13,444 8,134 AI Other Income 144 34 Other In
Slide 21: Quarterly Profit and Loss Statement
Quarterly Profit and Loss Statement Standalone Consolidated PARTICULARS (in INR Millions) Q2FY22 Q1FY22 Q2FY21 PARTICULARS (in INR Millions) Q2FY22 Q1FY22 Q2FY21 Revenue From Operations 5,263 6,897 3,914 Revenue From Operations 6,281 7,364 4,098 Other Income 90 55 15 Other Income 67 43 4 Total Incom
Slide 22: Balance Sheet Statement Standalone
Balance Sheet Statement Standalone PARTICULARS (in INR Millions) H1FY22 FY21 Shareholder Fund 11,523 10,445 Non Current Liabilities 334 300 Current Liabilities 5,771 6,602 Total Liabilities 17,628 17,348 Non Current Assets 5,142 4,548 Current Assets 12,486 12,799 Total Assets 17,628 17,348 w w w. l
Slide 23: Balance Sheet Statement Consolidated
Balance Sheet Statement Consolidated PARTICULARS (in INR Millions) H1FY22 FY21 Shareholder Fund 11506 10350 Non Current Liabilities 376 348 Current Liabilities 6566 7675 Total Liabilities 18449 18374 Non Current Assets 6520 5323 Current Assets 11929 13050 Total Assets 18449 18374 w w w. l a x m i .
Slide 24: Financial performance trend
Financial performance trend Revenue from operations EBITDA profile (INR Mn) (INR Mn) 16,061 2,025 14,288 13,587 12,160 1,514 1,608 1,176 FY19 FY20 FY21 H1FY22 FY19 FY20 FY21 H1FY22 PAT profile Return ratios (INR Mn) (%) 1,226 26% 1,090 21% 18% 19% 778 786 17% 16% 14% 12% FY19 FY20 FY21 H1FY22 FY19 F
Slide 25: Financial performance trend
Financial performance trend Asset turnover Working capital days (X) (days) 1.5 1.4 34 1.3 31 25 0.9 18 FY19 FY20 FY21 H1FY22 FY19 FY20 FY21 H1FY22 Leverage profile Cash Inflow from Operations before WC changes and CAPEX outgo (X) (INR Mn) 0.2 0.2 1,678 1,187 1,263 972 878 933 728 333 0.0 0.0 FY19 FY
Slide 26: Glossary
Glossary ¢ ETAC – Ethyl Acetate ¢ AI – Acetyl Intermediates ¢ SI – Specialty Intermediates ¢ DSIR – Department of Scientific and Industrial Research ¢ IFC – International Finance Corporation ¢ LOIL – Laxmi Organic Industries Ltd ¢ YCPL – Yellowstone Chemicals Pvt Ltd ¢ YFCPL – Yellowstone Fine Chemi
Slide 27: Thank You
THANK YOU For further details please get in touch with: LAXMI ORGANIC INDUSTRIES Email: investors@laxmi.com DIWAKAR PINGLE CHRISTENSEN ADVISORY Email: dpingle@christensenir.com
Laxmi Organic Industries — Q2 FY2022 Earnings Presentation on 6ix